| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $697K | +750.0% |
| Cost of Revenue | $272K | +750.0% |
| Gross Profit | $425K | +750.0% |
| R&D Expense | $7.0M | +37.3% |
| SG&A Expense | $7.4M | +16.2% |
| Operating Income | -$12.8M | -22.7% |
| Pre-tax Income | -$10.5M | -2.0% |
| Income Tax | -$24K | -2500.0% |
| Net Income | -$10.5M | -1.7% |
| EPS (Basic) | -$1.29 | +78.5% |
| EPS (Diluted) | -$1.29 | +78.5% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $374K | -94.8% |
| Accounts Receivable | $3K | — |
| Current Assets | $1.5M | -82.4% |
| Total Assets | $2.3M | -74.3% |
| Current Liabilities | $5.9M | +158.3% |
| Total Liabilities | $6.2M | +169.0% |
| Stockholders' Equity | -$3.9M | -159.7% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$7.7M | +4.4% |
| Capital Expenditures | $123K | +64.0% |
| Investing Cash Flow | -$123K | -64.0% |
| Financing Cash Flow | $1.0M | -84.7% |
| Free Cash Flow | -$7.9M | +3.8% |